De Burlo Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.94M | Sell |
10,045
-315
| -3% | -$171K | 1.12% | 27 |
|
|
2025
Q4 | $6M | Sell |
10,360
-125
| -1% | -$70.7K | 0.73% | 34 |
|
|
2025
Q3 | $5.09M | Sell |
10,485
-200
| -2% | -$93.1K | 0.61% | 36 |
|
|
2025
Q2 | $4.33M | Sell |
10,685
-215
| -2% | -$89.9K | 0.57% | 40 |
|
|
2025
Q1 | $5.42M | Buy |
10,900
+5
| +0% | +$2.71K | 0.8% | 33 |
|
|
2024
Q4 | $5.67M | Sell |
10,895
-425
| -4% | -$234K | 0.76% | 34 |
|
|
2024
Q3 | $7M | Hold |
11,320
| – | – | 0.86% | 32 |
|
|
2024
Q2 | $6.26M | Sell |
11,320
-515
| -4% | -$295K | 0.84% | 30 |
|
|
2024
Q1 | $6.88M | Sell |
11,835
-535
| -4% | -$300K | 0.91% | 30 |
|
|
2023
Q4 | $6.26M | Hold |
12,370
| – | – | 1.09% | 30 |
|
|
2023
Q3 | $6.26M | Buy |
12,370
+90
| +0.7% | +$48K | 1.09% | 30 |
|
|
2023
Q2 | $6.41M | Buy |
12,280
+93
| +0.8% | +$50.2K | 1.07% | 31 |
|
|
2023
Q1 | $7.02M | Sell |
12,187
-50
| -0.4% | -$28.2K | 1.37% | 26 |
|
|
2022
Q4 | $6.74M | Sell |
12,237
-110
| -0.9% | -$58.3K | 1.51% | 23 |
|
|
2022
Q3 | $6.26M | Buy |
12,347
+11,060
| +859% | +$6.19M | 1.49% | 21 |
|
|
2022
Q2 | $699K | Sell |
1,287
-11,063
| -90% | -$6.09M | 0.2% | 37 |
|
|
2022
Q1 | $7.29M | Sell |
12,350
-20,525
| -62% | -$11.8M | 1.36% | 22 |
|
|
2021
Q4 | $21.9M | Buy |
32,875
+2,340
| +8% | +$1.46M | 3.19% | 7 |
|
|
2021
Q3 | $17.4M | Buy |
30,535
+17,886
| +141% | +$9.82M | 2.83% | 9 |
|
|
2021
Q2 | $6.38M | Sell |
12,649
-15,740
| -55% | -$7.43M | 1.02% | 35 |
|
|
2021
Q1 | $13M | Sell |
28,389
-18,950
| -40% | -$9.04M | 2.32% | 16 |
|
|
2020
Q4 | $22M | Sell |
47,339
-100
| -0.2% | -$46.9K | 3.61% | 8 |
|
|
2020
Q3 | $20.9M | Buy |
47,439
+34,600
| +269% | +$14.3M | 3.81% | 5 |
|
|
2020
Q2 | $3.64M | Hold |
12,839
| – | – | 1.02% | 31 |
|
|
2020
Q1 | $3.64M | Buy |
12,839
+100
| +0.8% | +$31.5K | 1.02% | 31 |
|
|
2019
Q4 | $4.14M | Sell |
12,739
-9,900
| -44% | -$3M | 0.84% | 37 |
|
|
2019
Q3 | $6.59M | Sell |
22,639
-32,750
| -59% | -$9.38M | 1.48% | 23 |
|
|
2019
Q2 | $16.3M | Sell |
55,389
-4,550
| -8% | -$1.25M | 3.18% | 7 |
|
|
2019
Q1 | $16.4M | Sell |
59,939
-1,250
| -2% | -$311K | 3.31% | 5 |
|
|
2018
Q4 | $13.7M | Buy |
61,189
+8,900
| +17% | +$2.09M | 3.07% | 6 |
|
|
2018
Q3 | $12.8M | Buy |
52,289
+8,950
| +21% | +$2.06M | 2.39% | 9 |
|
|
2018
Q2 | $8.98M | Sell |
43,339
-4,311
| -9% | -$915K | 1.9% | 18 |
|
|
2018
Q1 | $9.84M | Buy |
47,650
+17,900
| +60% | +$3.76M | 2.14% | 16 |
|
|
2017
Q4 | $5.65M | Sell |
29,750
-3,250
| -10% | -$623K | 1.14% | 37 |
|
|
2017
Q3 | $6.24M | Buy |
33,000
+17,100
| +108% | +$3.1M | 1.38% | 27 |
|
|
2017
Q2 | $2.77M | Sell |
15,900
-150
| -0.9% | -$25.2K | 0.62% | 40 |
|
|
2017
Q1 | $2.46M | Sell |
16,050
-10,200
| -39% | -$1.56M | 0.54% | 49 |
|
|
2016
Q4 | $3.7M | Sell |
26,250
-43,800
| -63% | -$6.46M | 0.9% | 40 |
|
|
2016
Q3 | $11.1M | Buy |
70,050
+2,450
| +4% | +$378K | 3.09% | 2 |
|
|
2016
Q2 | $9.99M | Buy |
67,600
+30,800
| +84% | +$4.55M | 2.41% | 10 |
|
|
2016
Q1 | $5.21M | Buy |
36,800
+34,200
| +1,315% | +$4.58M | 1.51% | 26 |
|
|
2015
Q4 | $368K | Sell |
2,600
-100
| -4% | -$13.3K | 0.09% | 87 |
|
|
2015
Q3 | $330K | Hold |
2,700
| – | – | 0.08% | 87 |
|
|
2015
Q2 | $350K | Buy |
+2,700
| New | +$352K | 0.07% | 91 |
|
|
2015
Q1 | – | Sell |
-2,700
| Closed | -$338K | – | 111 |
|
|
2014
Q4 | $338K | Buy |
+2,700
| New | +$328K | 0.07% | 93 |
|
|
2014
Q3 | – | Sell |
-2,700
| Closed | -$319K | – | 106 |
|
|
2014
Q2 | $319K | Sell |
2,700
-100
| -4% | -$11.8K | 0.07% | 87 |
|
|
2014
Q1 | $337K | Hold |
2,800
| – | – | 0.08% | 83 |
|
|
2013
Q4 | $311K | Sell |
2,800
-350
| -11% | -$34.8K | 0.07% | 87 |
|
|
2013
Q3 | $290K | Hold |
3,150
| – | – | 0.08% | 81 |
|
|
2013
Q2 | $267K | Buy |
+3,150
| New | +$262K | 0.08% | 81 |
|
Other funds holding TMO
VCM
De Burlo Group's TMO Position: Q1 2026 in Review
De Burlo Group reduced its Thermo Fisher Scientific (TMO) stake by 3% in Q1 2026, selling an estimated $171K and leaving 10,045 shares worth $4.94M. The position accounts for 1.12% of the portfolio, ranked #27.
De Burlo Group first reported a position in TMO in Q2 2013 and has held it in 50 quarters since. The position peaked at $22M in Q4 2020. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- De Burlo Group held 10,045 shares of Thermo Fisher Scientific worth $4.94M as of Q1 2026.
- De Burlo Group sold 315 Thermo Fisher Scientific shares in Q1 2026, an estimated $171K.
- Thermo Fisher Scientific made up 1.12% of De Burlo Group's portfolio in Q1 2026, its #27 holding.
- De Burlo Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 50 quarters since.
- De Burlo Group's Thermo Fisher Scientific position peaked at $22M in Q4 2020.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on De Burlo Group's 13F filing for Q1 2026, filed 14 May 2026.